Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment

    Investment

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Medical Dialogues Bureau3 April 2020 2:17 PM IST
    New Delhi: Genetic diagnostics firm MedGenome has said it has raised USD 55 million (over Rs 415 crore) in funding led by LeapFrog...
    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    Medical Dialogues Bureau25 Feb 2020 1:06 PM IST
    California: SoftBank's second Vision Fund has led a new $165 million funding round in California-based Karius, which markets a test that can quickly...
    Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

    Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

    Medical Dialogues Bureau30 Jan 2020 4:15 PM IST
    Istanbul: Luxembourg-based Yamma Investments agreed to buy a 30% stake in Turkish generic drug maker Sanovel for $200 million, the target company's...
    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Slayback Pharma raises USD 50 million in Series B funding from Everstone Group

    Medical Dialogues Bureau7 Jan 2020 3:26 PM IST
    In addition to the investment, Everstone Managing Directors Arjun Oberoi and Puncham Mukim will join Slayback Pharma's Board of Directors. Everstone...
    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Farhat Nasim28 Dec 2019 10:00 AM IST
    "With 81 centres currently spread across the county, we would be coming up with 15-20 new centres in south India. We would be investing around Rs...
    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Medical Dialogues Bureau3 Oct 2019 4:34 PM IST
    New Delhi: Diagnostic chain Dr Lal PathLabs said the board of its arm PathLabs Unifiers has approved acquisition of 70 per cent stake in Amins...
    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
    Bengaluru,: Onco.com, India's only internet aggregator for cancer care, announced completion of $7 million in series A funding by Accel, Chiratae...
    Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru

    Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru

    Medical Dialogues Bureau22 Sept 2019 9:30 AM IST
    Siemens Healthineers has made a Rs 20-crore investment in a new manufacturing facility collocated with its RnD centre at Bengaluru.New Delhi: Medical...
    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Medical Dialogues Bureau20 Sept 2019 2:33 PM IST
    The Hyderabad Pharma City project has received an overwhelming response from the industry stakeholders, Telangana Minister for IT and Industries KT...
    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    Medical Dialogues Bureau27 Aug 2019 9:45 AM IST
    Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a...
    CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025

    CK Birla Hospital for Women to invest up to Rs 1,000 cr, add 14 hospitals by end of 2025

    Medical Dialogues Bureau12 Aug 2019 1:36 PM IST
    NEW DELHI: Healthcare provider CK Birla Hospital for Women is planning to invest up to Rs 1,000 crore to add around 14 more hospitals under the brand...
    Japanese medical equipment firm Nemoto Kyorindo plans to invest in Punjab

    Japanese medical equipment firm Nemoto Kyorindo plans to invest in Punjab

    Farhat Nasim6 July 2019 9:30 AM IST
    The Japanese firm is one of the world's leading producers of surgical tables, contrast agent injectors, and specialises in the field of medical image...
    Next

    Popular Stories

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok